MY ACCOUNT | NEWSLETTER |

Ambitious One Health Joint Action Plan launched to address global health threats


On Oct. 17, a new One Health Joint Plan of Action was launched by the Quadripartite – the Food and Agriculture Organization of the United Nations, the United Nations Environment Program, the World Health Organization, and the World Organization for Animal Health.

This first joint plan on One Health aims to create a framework to integrate systems and capacity to better prevent, predict, detect and respond to health threats, according to a news release. Ultimately, this initiative seeks to improve the health of humans, animals, plants, and the environment, while contributing to sustainable development.

The five-year plan — with a timeline from 2022 to 2026 — focuses on supporting and expanding capacities in six areas: One Health capacities for health systems, emerging and re-emerging zoonotic epidemics, endemic zoonotic, neglected tropical and vector-borne diseases, food safety risks, antimicrobial resistance and the environment.

The technical document relies on evidence, best practices and existing guidance. It covers a set of actions which endeavor to advance One Health at global, regional and national levels.

These actions notably include the development of an upcoming implementation guidance for countries, international partners, and non-State actors such as civil society organizations, professional associations, academia and research institutions.

Read the plan on the UNEP website.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

EXPRESS: Azotaemia and outcomes in male cats with initial and recurrent urethral obstruction: a multicentre retrospective study of 601 cats (2020-2024).

Like0
Dislike0

Clinical findings and risk factors for clinical outcomes in dogs with myxomatous mitral valve disease hospitalized for cardiogenic pulmonary edema.

Like0
Dislike0

Soluble triggering receptor expressed on myeloid cells-1 as a predictive biomarker in sepsis: insights into cut-offs, mortality risk, and treatment guidance-secondary analysis of the Next GeneSiS-Trial.

Like0
Dislike0

Texas A&M Research Reveals More Than 84% Of Dogs Show Signs Of Fear, Anxiety

Like0
Dislike0

Veterinary Pharmaceuticals Market Research and Global Forecast Report 2026-2031: Rising Demand for Parasiticides and Dermatology Products and Growth Potential in

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top